FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070823 [Registered on: 18/07/2024] Trial Registered Prospectively
Last Modified On: 18/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Ayurvedic treatment for Benign Prostatic Hyperplasia with Mustadi Gana Kwatha and Swadamstradi Taila 
Scientific Title of Study   A Phytochemical In Silico and Clinical Study of Mustadi Gana Kwatha and Swadamstradi Taila in the management of Benign Prostatic Hyperplasia 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Saradhi R 
Designation  Junior Resident 
Affiliation  Banaras Hindu University 
Address  Dept of Shalya Tantra Faculty of Ayurveda Institute of Medical Sciences Banaras Hindu University Varanasi

Varanasi
UTTAR PRADESH
221005
India 
Phone  7034466460  
Fax    
Email  saradhi1002@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Arun Kumar Dwivedi 
Designation  Assistant Professor 
Affiliation  Banaras Hindu University 
Address  Dept of Shalya Tantra Faculty of Ayurveda Institute of Medical Sciences Banaras Hindu University Varanasi

Varanasi
UTTAR PRADESH
221005
India 
Phone  9161499774  
Fax    
Email  drarunbhu@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sunil Kumar Mishra 
Designation  Assistant Professor 
Affiliation  Banaras Hindu University 
Address  Department of Pharmaceutical Engineering IT Banaras Hindu university

Varanasi
UTTAR PRADESH
221005
India 
Phone  7348476308  
Fax    
Email  skmishra.phe@itbhu.ac.in  
 
Source of Monetary or Material Support  
OPD of Department of Shalya Tantra Sir Sunderlal Hospital Faculty of Ayurveda Institute of Medical Sciences Banaras Hindu University Varanasi 
 
Primary Sponsor  
Name  Faculty of Ayurveda Institute of Medical SciencesBanaras Hindu University 
Address  Dept of Shalya Tantra Faculty of Ayurveda Institute of Medical Sciences Banaras Hindu University Varanasi 221005 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Saradhi R  Sir Sunderlal Hospital  OPD no 12 14 16A and NRC Dept of Shalya Tantra Faculty of Ayurveda Institute of Medical Sciences Banaras Hindu University Varanasi
Varanasi
UTTAR PRADESH 
7034466460

saradhi1002@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC, IMS, BHU  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N401||Benign prostatic hyperplasia withlower urinary tract symptoms. Ayurveda Condition: VATASHTHILA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Mustadi Gana Kwatha, Reference: Susruta Samhita Uttara Tantram Mutrakrichra Pratisheda , Route: Rectal, Dosage Form: Kwatha/ Kashaya, Dose: 120(ml), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 5 Days, anupAna/sahapAna: No, Additional Information: Kashaya basti with Mustadi gana kashaya in empty stomach
2Intervention ArmDrugClassical(1) Medicine Name: swadamstradi taialm, Reference: Susruta Samhita Uttara Tantram Mutrakrichra Pratisheda , Route: Rectal, Dosage Form: Taila, Dose: 70(ml), Frequency: od, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 10 Days, Reference: No, Route: -, Dosage Form: Taila, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  80.00 Year(s)
Gender  Male 
Details  diagnosed cases of BPH, without acute retention of urine
all grades of BPH without acute retention of urine 
 
ExclusionCriteria 
Details  Patients with bladder neck stenosis acute urinary retention known case of systemic diseases like TB Hepatitis B HIV Hepatitis C Cardiac diseases uncontrolled DM urethral stricture Neurogenic bladder ARF and CRF veneral diseases 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Disease specific subjective parameters based on IPSS score
objective parameters like weight of prostate and PVRU by USG whole abdomen with prostate and PVRU
 
Basti will be administered for a period of 15 days followed by follow up every 4 weeks for a period of 12 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Relief in signs and symptoms of BPH   for a period of 3months 
 
Target Sample Size   Total Sample Size="25"
Sample Size from India="25" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   10/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   On the basis of previous data and disease prevalence a total sample size of 25 has calculated after statistical analysis.Patients with signs and symptoms of BPH will be selected from OPD/IPD of department of Shalya Tantra and included in a single interventional group. Complete evaluation will be done by clinical examination, hematological, biochemical, radiological, urine analysis and uroflowmetry studies. Patients will be treated with Kala Basti for a period of 15 days;10 anuvasana basti with Swadamstradi Taila and 5 kashaya basti with Mustadi Gana Kashaya. After completion of therapy it will be assessed by subjective and objective parameters including urine flowrate(UFR), Post Voidal Residual Urine(PVRU) and size of prostate by USG. Statistical  analysis, Phytochemical ,In Silico study will be conducted on a computer through computational simulations. The biochemical, biophysical, biosaftey ,toxicity study and theraputics of Mustadi Gana Kashaya and Swadamstardi Taila will be studied. 
Close